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Saudi Journal of Ophthalmology (2012) 26, 229–234Case ReportFamilial bilateral combined hamartoma of retina and retinal
pigment epithelium associated with neurofibromatosis 1Sanaa A. Yassin, MD, FRCS ⇑; Elham R. Al-Tamimi, MDAbstractWe report a family of three siblings followed between 2005 and 2011 with bilateral combined hamartoma of the retina and retinal
pigment epithelium, with the age of diagnosis ranging from 7 to 13 years. The main reason for consultation was reduction of vision
and squint. The diagnosis was determined based on the clinical findings on fundus examination: increased pigmentation at the
macula with slightly elevated, gray–white macular lesion, tortuosity of perimacular blood vessels and glial epiretinal membrane.
The elder brother was found to have left posterior subcapsular cataract. He was also confirmed to have neurofibromatosis type
1, the youngest sister fit in the diagnostic criteria for neurofibromatosis type 1, while the middle sister was presumed to have
neurofibromatosis type 1. Follow-up showed stability of the retinal lesion in the three cases, with the progression to develop right
posterior subcapsular cataract in the elder sister.
This report is aimed to demonstrate that the occurrence of bilateral combined hamartoma of the retina and retinal pigment
epithelium could raise the possibility of associated neurofibromatosis.
Keywords: Combined hamartoma, Retinal pigment epithelium, Neurofibromatosis type 1, Bilateral, Familial
 2012 Saudi Ophthalmological Society, King Saud University. All rights reserved.
http://dx.doi.org/10.1016/j.sjopt.2012.03.005Introduction
Combined hamartoma of the retina and retinal pigment
epithelium (CHR-RPE) was initially described by Gass in
1973. These lesions have been characterized as benign,
hamartomatous, often elevated tumefactions involving the
RPE, retinal vasculature, and the vitreous. Hamartomas are
benign overgrowth of mature cells and tissues that occur
normally in the affected part. In case of combined hamar-
toma, one type of tissue (vascular, melanocytic or glial) of-
ten appears to dominate the clinical picture.18 Variations
can involve the lesions’ location as well. Gass divided the
RPE hamartomas into four groups according to their loca-
tion. The categories included lesions of the disk, lesions
adjacent to the disk, lesions in the mid-periphery, and le-
sions of the macular area.Peer review under responsibility
of Saudi Ophthalmological Society,
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epithelium is a benign lesion which occurs rarely and
sporadically in otherwise normal and healthy individuals,
though association between CHR-RPE and neurofibromatosis
type 1 (NF-1)3,6,16,2,19,20 and neurofibromatosis type 2
(NF-2)3,11,7,17,8,14 have been recognized.
Combined hamartomas of the retina and retinal pigment
epithelium in healthy individuals are usually described unilat-
erally. While bilateral CHR-RPE has been reported, but they
are rare.12,13,1
In this paper, we describe a family of three siblings having
bilateral combined hamartoma of the retina and retinal pig-
ment epithelium. The brother and father are confirmed to
have NF-1 and the youngest sister fit in the diagnostic criteria
for neurofibromatosis type 1, while the middle sister is
presumed to have neurofibromatosis type 1.j Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.comwww.sciencedirect.com
March 2012; available online 19 March 2012.
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Arabia. Tel.: +966 38605309; fax: +966 38966776.
230 S.A. Yassin, E.R. Al-TamimiCase 1
A 13-year-old young boy presented with the history of de-
creased vision in both eyes. He was having a neck deformity
on the left side (Fig. 1A) with paralysis of the left upper limb,
and a history of multiple surgeries. The best corrected visual
acuity in the right eye was 0.3 and in the left eye was 0.1.
There was a left relative afferent pupillary defect. Fixation
in right eye with 25 prism diopters left exotropia and normal
extra ocular muscle movements. Anterior segment of the
right eye was normal, while the left showed posterior subcap-
sular cataract (Fig. 1B). Fundus examination revealed gener-
alized pigment tessellation in both eyes. In addition, right
fundus showed peripapillary atrophy with increased pigmen-
tation at the macula with a slightly elevated gliotic gray–white
macular lesion (one and half disk diameter), involving the fo-
vea. The retinal vessels around the lesion appeared slightly
tortuous (Fig. 1C). The left fundus showed a large (12 disk
diameter) gliotic, elevated, heavily pigmented macular massFigure 1. (Case 1) (A) Showing neck deformity and scars of old surgery. (B) Sh
right eye showed peripapillary atrophy, increased pigmentation at the macu
vessels around the lesion appeared slightly tortuous. (D) The left fundus show
vessels are crossing through the lesion and around appeared quite tortuous w
showed right early hypo-fluorescence with later small area hyper-fluorescence
with hyper-fluorescence (arrow) on late films with no late leakage.with exudate like margins. The retinal vessels crossing
through the lesion and around appeared quite tortuous with
pre-retinal membrane dragging from the disk toward the
lesion (Fig. 1D).
Fundus fluorescein angiography (FFA) showed right early
hypo-fluorescence with later small area hyper-fluorescence
with no leakage (Fig. 1E). Left fundus showed multiple stip-
pling with hyper-fluorescence on late films with no late leak-
age (Fig. 1F).
A preliminary diagnosis of congenital toxoplasmosis caus-
ing retinal scar seemed appropriate. So it was decided to ob-
serve the patient. Three years later, on careful review of the
history, it was noted that the father had several surgeries per-
formed for cervical and spinal tumors and his two sisters have
decreased vision. His medical report stated that he was oper-
ated four times for left sided recurrent cervical plexiform
schwannoma. On systemic examination, there were multiple
skin nodules on the upper and lower extremities and on the
back of variable size, with only one ‘‘café-au-lait’’ spot onowing posterior subcapsular cataract in the left eye. (C) The fundus of the
la with a slightly elevated gliotic gray–white macular lesion. The retinal
ed a large gliotic, elevated, heavily pigmented macular mass. The retinal
ith epiretinal membrane dragging from the disk toward the lesion. (E) FFA
(arrow) with no leakage. (F) FFA of left fundus showed multiple stippling
Figure 2. (Case 1) (A) MRI of the brain axial view showed a lesion of high signal on T2 weighted images in the right frontal lobe (arrow) which represent
unidentified bright objects ‘‘UBO’’. (B) A large heterogeneous mass in the left side of the neck (arrow) showing heterogeneous signals with an intradural
extra-medullary extension which exerted a mass effect on the spinal cord, most likely represent plexiform neurofibromatosis.
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cervical region with an evidence of lower motor neuron affec-
tion of the left upper extremity.
Magnetic resonance imaging (MRI) of the brain showed
multiple lesions representing unidentified bright objects
(UBO) which were located in the right temporal, right frontal
(Fig. 2A), right parietal, left frontal, right and left occipital re-
gions and right centrum semi-oval. A scalp lesion of low sig-
nal on all sequences was also noted in the right parietal
region which represents hamartoma. A large heterogeneous
mass was seen in the left side of the neck; showing heteroge-
neous signals mainly low on T1 and high on T2 most likely
representing plexiform neurofibromatosis (Fig. 2B). These
changes were highly suggestive of neurofibromatosis type 1.Figure 3. (Case 2) (A) Fundus of right eye and (B) left eye showing increase
macular lesion, with a fibrotic band extending from the disk to the epimac
tortuous. (C) FFA showing minimal hyper-fluorescence in the left eye (arrow) an
MRI of the brain coronal view showing unidentified bright objects ‘‘UBO’’ anThe patient was followed for three more years with no
further progression or worsening of his ocular findings.Case 2
A 11-year-old girl, the sister of the first case was seen at
the age of eight complaining of ocular deviation of one year
duration with normal natal and prenatal periods. She gave
the family history of a brother having a problem in the retina.
Examination revealed best corrected visual acuity; right eye:
0.3 and left eye: 0.2 with 40 prism diopters alternate exotro-
pia with right eye preference. Anterior segments were within
normal in both eyes. Fundus examination showed bilaterald pigmentation at the macula and a slightly elevated, gliotic gray–white
ular membrane. The retinal vessels around the lesion appeared slightly
d a slight increase in vascular tortuosity. (D) MRI of the brain axial view. (E)
terior to the body of the left lateral ventricle (arrows).
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gliotic gray–white macular lesion, involving the fovea and in-
fra-temporal parts of the macula; with a fibrotic band extend-
ing from the disk to the epimacular membrane. The retinal
vessels around the lesion appeared slightly tortuous
(Fig. 3A and B). Preliminary diagnosis of a hereditary macular
lesion was considered and it was planned to observe it and to
see her brother and sister in the future visit. Three years later,
all the family members were reviewed together. The lesions’
size was the same but the pigmentation increased slightly in
the left macula.
After recognizing the positive family history of neurofibro-
matosis in father and brother, systemic examination did not
reveal any sign of the disease other than a small mole on
the left thigh. FFA revealed minimal hyper-fluorescence in
the left eye and a slight increase in the vascular tortuosity
(Fig. 3C).
MRI of the brain showed unidentified bright objects ante-
rior to the body of the left lateral ventricle (Fig. 3D and E). No
other abnormality was detected. The patient did not fit in the
diagnostic criteria of neurofibromatosis type 1. She was fol-
lowed up for additional three years. During follow-up, it
was noted that she developed right posterior subcapsular
cataract.Case 3
Seven-year-old girl was examined as her family was evalu-
ated for hereditary macular lesions. Systemic examination
showed right lower limb mole with three ‘‘café-au-lait’’ spots
on the lower back, and freckling under the arms.
Ocular examination showed uncorrected visual acuity in
right eye 1.0 and left eye 0.7. She fixates with both eyes.
Anterior segment was normal in both eyes. Fundus examina-
tion of both eyes showed an increased pigmentation at the
macula with a slightly elevated, gliotic grayish lesion which
was one and a half disk diameter, involving the fovea and
the upper nasal parts of the macula. Retinal vessels around
the lesion appeared normal in the right eye (Fig. 4A). While
the left eye showed prominent epiretinal membrane and
the retinal vessels around the macula which appeared slightly
tortuous and dragged toward the lesion (Fig. 4B). MRI of the
brain was within normal limits.
The patient was diagnosed as of neurofibromatosis type 1,
according to the Diagnostic Criteria from NIH Consensus
Development Conference Statement of Neurofibromatosis.13.Figure 4. (Case 3) (A) Fundus of right eye and (B) left eye showing increased
both eyes, with prominent epiretinal membrane and the retinal vessels appeaThe patient was followed for three more years with no further
progression or worsening of her ocular findings.
After reviewing the three siblings, the diagnosis of familial
bilateral combined hamartoma of retina and retinal pigment
epithelium with neurofibromatosis type 1 association was
made. Though according to the diagnostic criteria for neuro-
fibromatosis type 1 the middle sister does not have definite
signs of the disease, but she should be observed.
Diagnostic criteria for neurofibromatosis type 1 (NF-1) and
neurofibromatosis type 2 (NF-2)
NF-1
Diagnosis requires two or more of the following:
1. Six or more cafe-au-lait spots >5 mm in diameter in prepu-
bescent or >15 mm in diameter in postpubescent
individuals.
2. Two or more neurofibromas of any type or one plexiform
neurofibroma.
3. Freckling of axillary, inguinal, or other intertriginous areas.
4. Optic nerve glioma.
5. Two or more Lisch nodules.
6. A distinctive osseous lesion, such as sphenoid bone dyspla-
sia or thinning of the long-bone cortex, with or without
pseudoarthrosis.
7. A first-degree relative with NF-1 per the above criteria.
NF-2
Diagnosis requires either
1. Bilateral eighth-nerve masses seen with appropriate neuro-
radiologic imaging techniques.
or
1. A first-degree relative with NF-2 and either a unilateral
eighth-nerve mass or two of the following: (a) neurofibroma,
(b) meningioma, (c) glioma, (d) schwannoma, or (e) juvenile
posterior subcapsular cataract.
From NIH Consensus Development Conference Statement of Neurofibromatosis.13
Discussion
Neurofibromatosis is a genetic disorder in which affected
individuals develop both benign and malignant tumors at
an increased frequency. It is an autosomal dominant disorder
with high mutation rate. The diagnosis of NF-1 and NF-2 is
based on the clinical criteria initially established by the
National Institute of Health (NIH) Consensus Development
Conference on Neurofibromatosis in 1987.15 Our first case
presented in this paper falls into the NF-1 category. The thirdpigmentation at the macula with a slightly elevated, gliotic grayish lesion
red slightly tortuous and dragged toward the lesion in the left eye.
Table 1. Previous reported cases of CHR-RPE associated with NF-1.
Author, reference and year Number of cases Unilateral vs. bilateral
Cotlier (1977)3 One case Unilateral
Gass (1987)6 Three cases Two bilateral
Palmer et al. (1990)16 Two cases One bilateral
Destro et al. (1991)4 One case Unilateral
Bursztyn and Rodriguez (1999)2 One case Unilateral
Tsai and O’Brien (2000)19 One case Unilateral
Vianna et al. (2001)20 One case Bilateral
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tory and right lower limb mole with three ‘‘café-au-lait’’ spots
on the lower back, and freckling under the arms. However,
the second case had only a positive family history, a small
mole on the left thigh and posterior subcapsular cataract.
She does not meet the diagnostic criteria of neurofibromato-
sis and we presume that she carries the same genetic abnor-
mality. The fact that both first and second cases had posterior
subcapsular cataract made us suspicious that our cases repre-
sent NF type 2, but MRI scan was negative for acoustic neu-
roma. In this paper we are reporting three siblings with
bilateral combined hamartoma of the retina and retinal pig-
ment epithelium in NF-1 associated with posterior subcapsu-
lar cataract in two cases. Farther highly sensitive genetic tests
are in order.
The hallmark of CHR-RPE is an endophytic tumor at the le-
vel of sensory retina and retinal pigment epithelium, with var-
iable pigmentation.18 These lesions contain abnormal-
appearing retinal blood vessels, and associated with some
degree of traction at the vitreoretinal interface, producing
prominent pre-retinal gliosis and retinal vascular tortuosity.18
Heterogeneousity of CHR-RPE has been almost proposed
and emphasized by Schachat as a spectrum of lesions, from
vascular malformation alone at one end, to epiretinal mem-
brane (ERM) formation alone at the other end.18 The associ-
ation between the ERM in one eye and the CHR-RPE in the
other eye has been described in three case reports.20,11,7 In
our cases, the appearance of the lesions was variable clini-
cally and on FFA. The left eye of the first case showed a large
gliotic, elevated, heavily pigmented macular mass, and in his
right eye and the two eyes of the two sisters’ epiretinal pro-
liferation was more evident as documented by FFA with
some endophytic growth. We believe that the lesions in all
these three patients are CHR-RPE despite the atypical FFA
findings and we emphasize what has been described previ-
ously as variable expressivity and heterogeneousity of the
lesions.
CHR-RPE is seen unilateral in majority of otherwise healthy
cases. Schachat et al.18 reviewed 60 cases with combined
hamartomas, which were collected by members of The Mac-
ular Society and all cases were unilateral. Font et al.5 re-
viewed the literature between 1952 and 1988 and found 53
cases while only one bilateral case was reported by Laqua
et al.12 Most of the reports later had few cases, usually unilat-
eral except,13,1 reported one bilateral case each. So out of al-
most 120 reported generally healthy cases, only three cases
were bilateral.
Retinal tumors are occasionally seen in patients with neu-
rofibromatosis type 1 (NF-1). These are usually astrocytic
hamartomas or angiomas. Combined hamartomas of the ret-
ina and retinal pigment epithelium are tumors that have been
described in NF-1, but this association has not been defini-tively established yet. Bilateral CHR-RPE has been reported
in four cases out of 10 reported cases (Table 1).6,16,20
CHR-RPE has also been reported in association with NF-2.
Bilateral CHR-RPE has been reported in five cases out of 17
reported cases.7,17,8 Interest in the association between NF-
2 and CHR-RPE led some authorities to prospectively exam-
ine the individuals in families for these associations. Kaye
et al.9 found that seven out of nine cases had unilateral epire-
tinal membrane.
Klara and Gazi10 reported bilateral epiretinal membrane in
two cases and unilateral in two cases. Meyer et al. in 1995 re-
ported an epiretinal membrane in the macula or paramacular
area in 12 out of 15 patients and a CHR-RPE in macula of one
patient with epiretinal membrane in the other eye.
The main ocular manifestations of NF-1 are: Lisch nodules,
optic gliomas, plexiform neurofibromatosis of the lids, con-
genital glaucoma, and flat pigmented choroidal lesions with
rare retinal lesions. Posterior capsular cataract is the main
ocular manifestation of NF-2. In our first case, there was a
probable association between NF-1 and posterior capsular
cataract.
In conclusion, by reviewing our cases and the literature, we
believe that the CHR-RPE lesion can be an additional ocular
manifestation of neurofibromatosis type 1. Ophthalmologists
should be aware of the possible association between hamar-
toma and neurofibromatosis, and the occurrence of bilateral
CHR-RPE could raise the possibility of associated phacoma-
tosis. Variation of the origin of the hamartomatous cell types
is responsible for heterogeneous clinical picture of lesions in
CHR-RPE and thus represents a diagnostic challenge.References
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